Thomas Jefferson University, Jefferson College of Population Health
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD as faculty at Thomas Jefferson University, Jefferson College of Population Health brings several unique perspectives to care management. As a practicing internist, he has a long-standing interest in and commitment to hands on care delivery. Dr. Stefanacci has led several managed care organizations focused on caring for large patient populations under full capitation. He currently works with several health systems on population health improvement efforts.
On the policy side, Dr. Stefanacci served as Health Policy Scholar for the Centers for Medicare & Medicaid Services (CMS) where he focused on medication access. He has applied his expertise in healthcare policy in his teaching position at Thomas Jefferson University in their Jefferson College of Population Health. In his academic role he has near 600 publications in addition to delivering well over 1000 lectures both nationally and internationally, working with health systems on care improvement efforts.
An active member of several professional associations – Dr. Stefanacci has been active on both the American Society of Consultant Pharmacists (ASCP) and AMDA Foundation Boards as well as being honored as an honorary lifetime member for ASCP and the National Association of Directors of Nursing. Finally, Dr. Stefanacci has achieved recognition as a fellow in both the College of Physicians of Philadelphia and American Geriatric Society as well as several national awards.
Dr Stefanacci’s greatest accomplishment is the Go4theGoal Foundation (www.Go4theGoal.org ), a 501(c)(3) public charity that he founded with his family and friends when his oldest son Richard was diagnosed with Ewing’s sarcoma in May 2006. He developed the foundation with an intense focus after his son’s death on June 12, 2007. Since its inception, the foundation has raised several million dollars to assist hundreds of children affected by cancer at nearly 100 children’s hospitals across the country, while also funding cutting-edge research to find a cure.
Thursday, November 3, 2022
3:30 PM – 5:30 PM ET